Volume 52, Issue 4 | Journal of Thrombosis and Thrombolysis

Journal of Thrombosis and Thrombolysis

A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science

Publishing model:: Hybrid

Submit your manuscript

Search all Journal of Thrombosis and Thrombolysis articles

Volume 52, Issue 4

November 2021

Special Issue: International COVID-19 Biomarkers (ICODE) Group

Issue Editors:

Richard C. Becker,
Diana Gorog

36 articles in this issue

International COVID-19 biomarkers colloquium
Richard C. Becker
Diana A. Gorog
Editorial 04 November 2021 Pages: 983 - 984
Screening for venous thromboembolism in patients with COVID-19
Christophe Vandenbriele
Diana A. Gorog
OriginalPaper Open access 21 May 2021 Pages: 985 - 991
International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests
Paul A. Gurbel
Udaya S. Tantry
Robert F. Storey
OriginalPaper 22 May 2021 Pages: 992 - 998
Incidence of thrombotic complications in COVID-19
William J. Jenner
Diana A. Gorog
OriginalPaper Open access 28 May 2021 Pages: 999 - 1006
Venous and arterial thromboembolic disease in COVID-19
J. ten Berg
OriginalPaper 13 July 2021 Pages: 1007 - 1009
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles
Richard C. Becker
Travis Sexton
for the International COVID-19 Thrombosis Biomarkers Colloquium (ICODE) Investigators
OriginalPaper 04 August 2021 Pages: 1010 - 1019
Ruthenium chloride inhibits the anticoagulant activity of the phospholipase A₂-dependent neurotoxin of Mojave rattlesnake Type A venom
Vance G. Nielsen
Letter to the Editor 08 May 2021 Pages: 1020 - 1022
Stroke risk factors and outcomes among hospitalized women with atrial fibrillation
Gregory Piazza
Shelley Hurwitz
Samuel Z. Goldhaber
OriginalPaper 26 May 2021 Pages: 1023 - 1031
External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19
Mark Goldin
Stephanie K. Lin
Alex C. Spyropoulos
BriefCommunication 19 June 2021 Pages: 1032 - 1035
Analysis of changes in the expression pattern of miR-326 and miR-145 during storage of platelet concentrate in blood bank condition and its relationship with some markers of platelet quality
Mozhgan Norouzi
Seyed Alireza Mesbah-Namin
Mohammad Reza Deyhim
OriginalPaper 11 May 2021 Pages: 1036 - 1042
Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson’s syndrome
Luca Roncati
Lorenzo Corsi
Giuseppe Barbolini
Report 12 April 2021 Pages: 1043 - 1046
Impact of the pandemic of COVID-19 on emergency attendance for stroke and acute myocardial infarction in Beijing, China
Yiqun Wu
Fei Chen
Haiqing Song
OriginalPaper 26 April 2021 Pages: 1047 - 1055
Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale
Daniel L. Eisenson
Oluwafemi P. Owodunni
Elliott R. Haut
Report 03 May 2021 Pages: 1056 - 1060
The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study
Matsuo So
David J. Steiger
Toshiki Kuno
OriginalPaper 08 May 2021 Pages: 1061 - 1067
Routine screening for pulmonary embolism in COVID-19 patients at the emergency department: impact of D-dimer testing followed by CTPA
Daniël A. Korevaar
Ilayda Aydemir
Josien van Es
BriefCommunication Open access 23 June 2021 Pages: 1068 - 1073
Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross‐sectional study
Frederico Bartolazzi
Antônio Luiz Pinho Ribeiro
Maria Auxiliadora Parreiras Martins
OriginalPaper 15 April 2021 Pages: 1074 - 1080
Meta-analysis of restrictive versus liberal blood transfusion among patients with coronary artery disease
Babikir Kheiri
Moinuddin Syed
Mohammed Osman
Letter to the Editor 06 May 2021 Pages: 1081 - 1083
Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis
Yong Yang
Xuyi Zhang
Qing Zhao
ReviewPaper 09 May 2021 Pages: 1084 - 1093
Venous thromboembolism in non-COVID-19 population during the pandemic: a nationwide multicenter retrospective survey
Cheng Qian
Xiao Lyu
Jian-Ping Gu
OriginalPaper 14 May 2021 Pages: 1094 - 1100
Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
Margaret C. Fang
Alan S. Go
Kristi Reynolds
OriginalPaper Open access 08 April 2021 Pages: 1101 - 1109
Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy
Nijole Bernaitis
Tony Badrick
Shailendra Anoopkumar-Dukie
OriginalPaper 07 May 2021 Pages: 1110 - 1116
Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial
Molly Elizabeth Droege
Christopher Allen Droege
Eric William Mueller
OriginalPaper 12 May 2021 Pages: 1117 - 1128
Primary pulmonary artery sarcoma versus pulmonary thromboembolism: a multimodal imaging comparison
Ellen Kronzer
Steven I. Robinson
Robert D. McBane II
Letter to the Editor 07 May 2021 Pages: 1129 - 1132
Double positivity of anti-β₂-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies enhances both thrombosis and positivity of anti-ADAMTS13 antibody
Jiwon Yun
JaYoon Gu
Hyun Kyung Kim
BriefCommunication 29 April 2021 Pages: 1133 - 1136
Prothrombin complex concentrate in major bleeding associated with DOACs; an updated systematic review and meta-analysis
Ioannis Milioglou
Ioannis Farmakis
Maria Papaioannou
OriginalPaper 23 May 2021 Pages: 1137 - 1150
Safety and efficacy of catheter-directed therapy versus anticoagulation alone in a higher-risk acute pulmonary embolism population
Andrew Putnam
Kyle Carey
Jonathan Paul
OriginalPaper 25 May 2021 Pages: 1151 - 1159
Is an antithrombotic strategy after transcatheter aortic valve implantation clearer now?
Meina Lv
Shaojun Jiang
Jinhua Zhang
Letter to the Editor 24 May 2021 Pages: 1160 - 1164
The use of recombinant tissue plasminogen activator in in acute ischemic stroke is associated with increased level of BDNF
Rasha Soliman
Hend Mamdouh
Mona Hussein
OriginalPaper 08 April 2021 Pages: 1165 - 1172
Safety of intravenous thrombolysis in stroke of unknown time of onset: A systematic review and meta-analysis
Chen Wang
Wanting Wang
Yujie Wang
ReviewPaper 07 May 2021 Pages: 1173 - 1181
Management of tandem occlusions in patients who receive rtPA
Keaton S. Smetana
Amanda Zakeri
Shahid M. Nimjee
OriginalPaper 23 June 2021 Pages: 1182 - 1186
Hospitalization for venous thromboembolic disease management: a 10 years Registry in Buenos Aires, Argentina
Fernando Javier Vázquez
Maria Florencia Grande-Ratti
Maria Lourdes Posadas-Martinez
OriginalPaper 26 April 2021 Pages: 1187 - 1194
Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study
Dragos Vinereanu
Dmitry Napalkov
Jiří Vesely
OriginalPaper Open access 30 April 2021 Pages: 1195 - 1206
Prior use of anticoagulation is associated with a better survival in COVID-19
A. G. Buenen
Marijn Sinkeldam
Peter C. Wever
BriefCommunication 01 June 2021 Pages: 1207 - 1211
Thrombectomy for ischemic stroke with large vessel occlusion and concomitant subarachnoid hemorrhage
Cecilia Zivelonghi
Andrea Emiliani
Manuel Cappellari
Report 08 June 2021 Pages: 1212 - 1214
A rare case of non-traumatic spinal epidural hematoma in lumbar region associated with apixaban therapy
Petr Krupa
Martin Kanta
Tomas Cesak
BriefCommunication 06 May 2021 Pages: 1215 - 1219
Thrombocytosis and neutrophilia associated with oxygenator failure and protamine reaction after cardiopulmonary bypass: a case report and literature review
Vance G. Nielsen
Toshinobu Kazui
Victoria E. Dotson
OriginalPaper 28 September 2021 Pages: 1220 - 1226